BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15650969)

  • 1. [Advances in therapy for ascites and hepatorenal syndrome].
    Gerbes AL; Gülberg V
    Z Gastroenterol; 2005 Jan; 43(1):31-4. PubMed ID: 15650969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of albumin infusion in decompensated liver cirrhosis].
    Schmidt LE; Ring-Larsen H
    Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory ascites: can it be defined only by the response to furosemide and spironolactone?
    Kalambokis G; Tsianos EV
    Liver Int; 2010 Oct; 30(9):1394; author reply 1395-6. PubMed ID: 20738777
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
    Fimiani B; Guardia DD; Puoti C; D'Adamo G; Cioffi O; Pagano A; Tagliamonte MR; Izzi A
    Eur J Intern Med; 2011 Dec; 22(6):587-90. PubMed ID: 22075285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascites and spontaneous bacterial peritonitis: an Asian perspective.
    Lee JM; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1494-503. PubMed ID: 19743995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study.
    Péron JM; Bureau C; Gonzalez L; Garcia-Ricard F; de Soyres O; Dupuis E; Alric L; Pourrat J; Vinel JP
    Am J Gastroenterol; 2005 Dec; 100(12):2702-7. PubMed ID: 16393223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations.
    Pericleous M; Sarnowski A; Moore A; Fijten R; Zaman M
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):e10-8. PubMed ID: 26671516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ascites, spontaneous bacterial peritonitis, hepatorenal syndrome: What is common in their diagnosis and treatment?].
    Bakulin IG; Varlamicheva AA
    Ter Arkh; 2015; 87(4):77-83. PubMed ID: 26087639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in treatment of massive ascites and hepatorenal syndrome.
    Gerbes AL; Gulberg V
    World J Gastroenterol; 2006 Jan; 12(4):516-9. PubMed ID: 16489662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The patient with refractory ascites.
    Gerbes AL
    Best Pract Res Clin Gastroenterol; 2007; 21(3):551-60. PubMed ID: 17544117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin: Indications in chronic liver disease.
    Tufoni M; Zaccherini G; Caraceni P; Bernardi M
    United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental methods in hepatology. Guidelines of the German Work Group for Study of the Liver. Therapy of ascites in liver diseases. German Work Group for Study of the Liver].
    Gerbes AL
    Z Gastroenterol; 1997 Apr; 35(4):295-300. PubMed ID: 9221613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
    Ginès P; Wong F; Watson H; Terg R; Bruha R; Zarski JP; Dudley F;
    Aliment Pharmacol Ther; 2010 Apr; 31(8):834-45. PubMed ID: 20102356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatorenal syndrome].
    Mijac D; Kezić A; Stojimirović B
    Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical indications for the albumin use: still a controversial issue.
    Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
    Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.